Can low testosterone cause ED? How often it's the real cause, and why fixing T doesn't always fix erections

The short version: low testosterone can play a part in erectile dysfunction, but it is the main driver far less often than the internet suggests. Low testosterone mostly drains desire; the physical act of getting and keeping an erection runs on blood flow and nerves, which is what ED medications like sildenafil and tadalafil target. In clinic studies, most men who come in with ED have testosterone in the normal range. That is why a blood test, not a symptom checklist, decides whether hormones are part of your picture, and why raising testosterone does not reliably fix erections on its own.

Can low testosterone cause ED?

Yes, low testosterone can cause or worsen erectile dysfunction, but it is rarely the only cause and it is not the most common one. Testosterone helps the penis release nitric oxide, the signal that starts the blood-flow response, so a real deficiency can weaken erections and blunt the desire that gets things started (Rizk et al., Curr Opin Urol, 2017). Federal health information lists low testosterone as one cause among several, alongside blood-vessel, nerve, medication and psychological causes (NIH NIDDK). So the honest answer to “can low testosterone cause ED” is yes, sometimes, and only testing tells you whether it is doing so in your case.

How often is low testosterone the real cause of ED?

Low testosterone shows up in a minority of men with ED, and how big that minority looks depends heavily on where the cutoff is drawn. In a retrospective review of 2,794 men aged 25 to 80 who were seen for a primary complaint of ED and had their total testosterone measured, 7% were below 200 ng/dL, 23% below 300 ng/dL, 33% below 346 ng/dL and 47% below 400 ng/dL (Köhler et al., Urology, 2008). The same study saw low levels jump in men aged 45 to 50 and stay at that plateau into old age, and found lower testosterone tied to age, uncontrolled diabetes, high cholesterol and anemia. Read the middle cutoff and roughly three in four of those men had testosterone at or above 300 ng/dL, so for most of them a hormone shortage, at least by that cutoff, was not the explanation. Put that next to how common ED itself is: federal estimates put it at 30 million to 50 million men in the United States, with about 40% affected at age 40 and 70% reporting ED by age 70 (NIH NIDDK). Low testosterone is part of that story, not the bulk of it.

Low T vs other causes of ED: a side-by-side

Each cause of ED is checked and treated differently, which is why the cause matters more than the label. The table pulls together what the cited sources say about how often each one turns up, how a clinician looks for it and what tends to help.

Sources for the table: Köhler et al., 2008; Huang et al., J Chin Med Assoc, 2019; Endocrine Society, 2018; Rizk et al., 2017; NIH NIDDK causes, risk factors and treatment; AUA ED guideline; Asian J Androl, 2014. The percentages come from clinic populations, so they describe those groups, not every man with ED.

Does low testosterone cause ED, or do they just show up together?

Often they show up together because they share the same upstream drivers, not because one causes the other. Excess weight, type 2 diabetes and metabolic disease all push testosterone down (Asian J Androl, 2014), and those same conditions damage the blood vessels that erections rely on (NIH NIDDK). In the ED review above, uncontrolled diabetes and high cholesterol tracked with lower testosterone (Köhler et al., 2008). So a low reading does not automatically mean the hormone is the reason for your ED. It might be a bystander, a contributor or the whole story, and fixing the number while leaving the shared driver untouched often leaves the erection problem in place.

Can low testosterone cause ED in young men?

It can, but most young men with ED have normal hormones. In a review of 2,292 men aged 18 to 40 who came in for ED, 2,130 had testosterone measured; the average was 368 ng/dL and 10.7% were hypogonadal (Huang et al., 2019). The authors concluded that the majority of men under 40 with ED have a normal hormonal picture. Low testosterone was more likely in the young men who had a higher body mass index, were over 34, had a cancer diagnosis or had depression. Depression and anxiety were also the most common conditions the group was being treated for, which is a reminder that mood belongs in the conversation too, and that a testosterone test is a check, not a presumed answer.

What low testosterone affects that an ED pill doesn’t

Low testosterone mainly drives sexual desire, energy and mood, while a PDE5 inhibitor acts on the plumbing of a single erection. Clinical guidelines treat low libido as one of the more specific signals of a genuine hormone deficiency, unlike vague complaints such as tiredness that have many causes (Endocrine Society, 2018). An oral ED medication works much further downstream and does not touch the hormone at all; our explainer on how ED medications work walks through that mechanism. The table below lines up the two conditions.

Why testing total and free testosterone matters

A blood test is the only way to know whether low testosterone is part of your ED, because the symptoms overlap with too many other conditions to guess. For men with ED, the American Urological Association recommends measuring morning serum total testosterone (AUA ED guideline), and confirming a deficiency takes at least two early-morning measurements rather than a single draw (AUA testosterone-deficiency guideline). The Endocrine Society guideline adds that the samples should be fasting morning draws on an accurate assay, and that the diagnosis needs both symptoms and consistently low levels (Endocrine Society, 2018). Timing matters because testosterone peaks in the morning, so an afternoon sample can read falsely low. Total testosterone is the headline number, but most testosterone in the blood is bound to proteins; the free fraction is what tissues can use. When the total sits near the lower limit of normal, or a condition alters the binding protein, the same guideline recommends measuring or calculating free testosterone, because a man with a normal total can still be functionally low. If you want to understand the signs first, our companion overview of low testosterone symptoms at TRT Clarity walks through what does and does not point to a hormone problem.

Does TRT fix ED?

Testosterone therapy improves erections for some men with confirmed low testosterone, but the effect is modest and it is not a substitute for ED-specific treatment. The evidence here is randomized trials and a meta-analysis of them, which is a fairly strong base. A 2017 meta-analysis of 14 placebo-controlled trials with 2,298 men found that testosterone therapy improved the erectile-function score of the International Index of Erectile Function by 2.31 points over placebo, with a larger gain in men with more severe deficiency (total testosterone below 8 nmol/L) and a smaller one in men with diabetes or obesity (Corona et al., Eur Urol, 2017). The authors suggested testosterone alone may be reasonable for hypogonadal men with milder ED, while men with more severe ED may need a PDE5 inhibitor added. In the Testosterone Trials, 470 men aged 65 and over with low libido and testosterone below 275 ng/dL used testosterone gel or placebo for a year; testosterone improved sexual activity, desire and erectile function, but rising hormone levels tracked with better desire and activity, not with better erections (Cunningham et al., JCEM, 2016). And in men with ED and low testosterone who were already taking sildenafil, adding testosterone gel did no better than placebo at improving erectile function (Spitzer et al., Ann Intern Med, 2012). The pattern is consistent: testosterone helps desire more reliably than it helps the mechanics of an erection (Rizk et al., 2017).

When testosterone therapy helps ED, and when it doesn’t

Testosterone therapy is most likely to help erections when ED is mild and testosterone is genuinely low, and least likely to help when ED is moderate to severe or testosterone is already normal. If you have lab-confirmed low testosterone and mild erectile difficulty, treating the deficiency can improve both desire and erections (Rizk et al., 2017). If your testosterone is normal, adding more is not a treatment for ED; guidelines reserve testosterone for men with an actual deficiency, not as a performance booster (Endocrine Society, 2018). And some men with low testosterone who did not respond well to an ED pill alone do respond once the deficiency is corrected, which is why a clinician may treat low testosterone before deciding a PDE5 inhibitor has failed (Rizk et al., 2017). That is also why over-the-counter “test boosters” are a poor answer to either problem; our look at testosterone therapy versus testosterone boosters at TRT Clarity explains why the supplements rarely move a real deficiency.

Can you use an ED medication and testosterone together?

Yes. Under a clinician’s supervision, a PDE5 inhibitor and testosterone therapy are sometimes used together, because they fix different parts of the problem. The American Urological Association notes that for men with both ED and a confirmed testosterone deficiency, a PDE5 inhibitor may work better combined with testosterone therapy than alone (AUA ED guideline), and federal health information says clinicians may prescribe testosterone with a PDE5 inhibitor for men who have ED and low testosterone, as a gel, a patch or an oral medicine (NIH NIDDK). That is a supervised combination for a specific situation, not a default stack for every man, and it only makes sense when testing has actually shown low testosterone.

What are the side effects of treating low T or ED?

The two treatments carry different risks, so the cautions differ too. For testosterone, the Endocrine Society recommends against starting therapy in men planning to father a child soon, or with breast or prostate cancer, a prostate nodule, a PSA above 4 ng/mL (above 3 ng/mL in higher-risk men) without further urology review, a high hematocrit, untreated severe sleep apnea, severe urinary symptoms, uncontrolled heart failure, a heart attack or stroke in the past six months, or a clotting disorder. Men on therapy are monitored for symptoms, side effects, testosterone level, hematocrit and prostate cancer risk during the first year (Endocrine Society, 2018). For PDE5 inhibitors, the common effects on the sildenafil label are headache, flushing, indigestion, a stuffy nose and a brief tint to vision (VIAGRA label), and federal health information flags an erection lasting over four hours and vision or hearing loss as reasons to seek care right away (NIH NIDDK). Our page on sildenafil side effects breaks down how often each one showed up in the label’s trials.

What else causes ED besides low testosterone?

Conditions that harm blood flow are a major group of drivers. Federal health information groups the causes into problems with blood vessels, nerves and hormones, and lists diabetes and heart and blood-vessel diseases such as atherosclerosis and high blood pressure among the most common conditions that can lead to ED (NIH NIDDK). Nerve damage from multiple sclerosis, spinal cord injury or pelvic surgery can interrupt the signal an erection needs. Blood pressure medicines and antidepressants can contribute, and anxiety, depression, stress, loneliness and low self-esteem can cause ED or make a physical case worse (NIH NIDDK causes; NIH NIDDK risk factors). Smoking, heavy drinking and inactivity are named lifestyle contributors, and federal guidance notes that a healthy weight can improve testosterone levels (NIH NIDDK treatment). That is the practical reason a clinician looks past testosterone: fixing one hormone while ignoring uncontrolled blood pressure, unmanaged blood sugar or a medication side effect leaves the real driver in place.

ED can be an early warning sign, not just a nuisance

Erectile dysfunction is a recognized risk marker for cardiovascular disease, so it is worth investigating the cause rather than only masking the symptom. The vessels that supply the penis are small, so they can show damage from atherosclerosis before the larger arteries of the heart do. Clinical guidelines advise that men be counseled that ED is a risk marker for underlying cardiovascular disease that may warrant its own evaluation (AUA ED guideline), and federal health information frames ED as a possible symptom of another health problem, including diabetes and heart and blood-vessel disease (NIH NIDDK). Our companion guide to what your ED says about your health walks through, system by system, the problems that ED can flag first.

The two ED medications, and how they are dosed

Sildenafil and tadalafil are both FDA-approved prescription PDE5 inhibitors, and they differ mainly in how long they last. Sildenafil, the generic form of Viagra, is usually taken about an hour before sex, works within a window of roughly 30 minutes to 4 hours, and has a terminal half-life of about 4 hours, which makes it a take-it-when-you-need-it option (VIAGRA label). Tadalafil, the generic form of Cialis, lasts far longer: its half-life is about 17.5 hours, it can improve erections for up to 36 hours after a dose, and it also comes in a low daily dose that keeps a steady level in your system so sex does not have to be planned around a pill (CIALIS label). Neither one raises testosterone or increases desire; they make it easier to get an erection when arousal is already there. Which one fits depends on how often and how spontaneously you want sex, your other medications, and side effects, and it is worth reading how sildenafil and tadalafil compare before you have that conversation. One more note on the crowded “sexual wellness” market: PT-141, or bremelanotide, is sometimes marketed to men for desire, but its approved product, Vyleesi, is cleared by the FDA only for premenopausal women with hypoactive sexual desire disorder and is explicitly not indicated for men, so any use in men is off-label, and our guide to PT-141 for men explains what that means (Vyleesi label).

How do the costs of TRT and ED medication compare?

The two paths cost money in different ways. Testosterone therapy is an ongoing treatment with a monitoring plan built in: symptom checks, testosterone and hematocrit measurements, and a prostate cancer risk review during the first year, and the Endocrine Society names cost and treatment burden among the factors in choosing a formulation (Endocrine Society, 2018). So the real cost of TRT includes repeat lab work and follow-up visits, not just the medication; our TRT cost breakdown at TRT Clarity walks through those pieces. An as-needed ED pill is a per-use cost that scales with how often you take it, while a daily tadalafil regimen is a steady monthly one. If testing shows normal testosterone, the cheapest honest answer is often not to start hormone therapy at all.

What do people get wrong about low T and ED?

Several assumptions about low T and ED come up again and again. Here is how each one holds up against the studies cited on this page.

How to tell whether low testosterone is driving your ED

The only reliable way to tell is to pair your symptoms with morning bloodwork and a clinician’s read. A useful rule of thumb points the way before any test: if the dominant change is that you no longer want sex, low testosterone climbs the list of suspects; if desire is intact but erections have gone soft, a vascular or nerve cause is more likely. That instinct still has to be checked against numbers. A sensible workup starts with two early-morning testosterone measurements, adds free testosterone when the total is borderline, and looks at the whole picture: blood pressure, blood sugar, cholesterol, medications, sleep, mood and habits (AUA ED guideline; Endocrine Society, 2018). From there, a licensed clinician can assess whether an ED medication fits, whether your testosterone needs treating, or whether the more important finding is a cardiovascular or metabolic issue. Our guide on when to see a doctor about ED covers what that first visit usually involves.

The bottom line

Low testosterone can cause or worsen ED, but in clinic studies most men with ED have testosterone at or above 300 ng/dL, and blood vessels, nerves, medicines, mood and habits are common drivers too. Low testosterone is mostly about lost desire and is confirmed by repeat morning bloodwork. Correcting a real deficiency helps some men, mainly those with milder ED, while PDE5 inhibitors like sildenafil and tadalafil address the mechanics of the erection itself, and the two are sometimes combined under supervision. Because ED can be an early flag for heart disease or diabetes, the smartest first move is finding the cause, not chasing a single fix.

Sources

Every clinical statement on this page traces to a primary or guideline source:

• American Urological Association, Erectile Dysfunction guideline: PDE5 inhibitors as a first-line option, morning total testosterone measurement, the combination of a PDE5 inhibitor with testosterone therapy in men with confirmed deficiency, and ED as a risk marker for cardiovascular disease.
• NIH, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Erectile Dysfunction symptoms and causes: the vascular, neurological, hormonal and psychological causes of ED, diabetes as a common cause, and ED as a possible symptom of another health problem.
• NIH NIDDK, Definition and Facts for Erectile Dysfunction: 30 million to 50 million US men with ED, about 40% at age 40 and 70% by age 70, and risk factors including diabetes, heart disease, obesity, blood pressure medicines, antidepressants, anxiety, stress, smoking and alcohol.
• NIH NIDDK, Treatment for Erectile Dysfunction: lifestyle changes, counseling, medication review, PDE5 inhibitors, testosterone with PDE5 inhibitors for men with ED and low testosterone, other ED treatments, and the warning signs that need urgent care.
• Köhler TS, et al. Prevalence of androgen deficiency in men with erectile dysfunction (Urology, 2008): in 2,794 men seen for ED, 7%, 23%, 33% and 47% had testosterone below 200, 300, 346 and 400 ng/dL; links to age, uncontrolled diabetes, high cholesterol and anemia.
• Huang IS, et al. Risk factors for hypogonadism in young men with erectile dysfunction (J Chin Med Assoc, 2019): 10.7% of men aged 18 to 40 with ED were hypogonadal, with comorbidity rates and risk factors.
• Corona G, et al. Meta-analysis of results of testosterone therapy on sexual function based on IIEF scores (Eur Urol, 2017): 14 placebo-controlled trials, 2,298 men; erectile-function gains larger in severe deficiency and smaller with diabetes or obesity.
• Cunningham GR, et al. Testosterone treatment and sexual function in older men with low testosterone levels (J Clin Endocrinol Metab, 2016): the Testosterone Trials sexual function results in 470 men aged 65 and over.
• Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline (J Clin Endocrinol Metab, 2018): diagnosis with repeat fasting morning tests, free testosterone, reserving therapy for confirmed deficiency, conditions where therapy should not be started, and monitoring.
• American Urological Association, Evaluation and Management of Testosterone Deficiency guideline: the diagnostic standard of two early-morning testosterone measurements.
• Rizk PJ, Kohn TP, Pastuszak AW, Khera M. Testosterone therapy improves erectile function and libido in hypogonadal men (Curr Opin Urol, 2017): testosterone improves desire more reliably than erectile mechanics, helps mild ED more than severe ED, and can help some PDE5-inhibitor non-responders.
• Spitzer M, et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial (Ann Intern Med, 2012): adding testosterone to sildenafil was not superior to placebo for erectile function in men with ED and low testosterone.
• VIAGRA (sildenafil citrate) FDA label via DailyMed: dosing and timing, roughly 4-hour half-life, common side effects, the nitrate contraindication, alpha-blocker caution, and the greater-than-4-hour erection warning.
• CIALIS (tadalafil) FDA label via DailyMed: as-needed and once-daily dosing, the 17.5-hour half-life and up-to-36-hour effect window, the nitrate contraindication including the 48-hour rule, and the priapism warning.
• VYLEESI (bremelanotide) FDA label via DailyMed: approved only for premenopausal women with acquired, generalized HSDD, and explicitly not indicated for men.
• Feldman HA, et al. Age trends in the level of serum testosterone: longitudinal results from the Massachusetts Male Aging Study (J Clin Endocrinol Metab, 2002): average total testosterone declines roughly 1 to 2 percent per year through middle age.
• Lowered testosterone in male obesity: mechanisms, morbidity and management (Asian J Androl, 2014): obesity and metabolic disease as drivers of lowered testosterone in men.